FreeStyle Libre 3+

Manage your diabetes with the world's smallest*1 15-day sensor, so you can get back to doing more of what you love.

Painless to apply1
Easy to apply and wear3, without the need for fingersticks§.
Affordable
More people pay $0 for FreeStyle Libre systems than any other CGMs‖1.
Discreet
The world’s smallest, thinnest*, and most discreet1 sensor.
Accurate and reliable
Proven to be accurate2 and 5x faster¶4 than other CGMs. Optional alarms# let you know
the minute your glucose is too high or too low.

Please review all the safety information here.

The FreeStyle Libre
3 system is indicated for use in people with diabetes age 4 and older.

Medicare and other
payor criteria may apply. Abbott provides this information as a courtesy and
does not guarantee payment or coverage.

* Among
patient-applied sensors.

† or ♢ Eligible patients will receive one
(1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3 system sensor for
users with a compatible mobile phone operating system at $0 copay. The
expiration date of the voucher is 60 days from the issue date. This program is
available for patients with Type 1 diabetes or Type 2 diabetes or gestational
diabetes. Patients ages 18 and older are eligible to sign up and receive an
offer for the (1) FreeStyle Libre 2 system sensor or (1) FreeStyle Libre 3
system sensor. Patients ages 4-17 are eligible to receive an offer for the (1)
FreeStyle Libre 2 sensor or (1) FreeStyle Libre 3 sensor through their parent
or guardian. Patients ages 2-17 are eligible to receive an offer for the (1)
FreeStyle Libre 2 Plus sensor or (1) FreeStyle Libre 3 Plus sensor through
their parent or guardian. This offer is void where prohibited by law. Abbott
may modify or rescind this offer at any time without notice. The discounts are
not available to beneficiaries of Kaiser Permanente, Medicare, Medicaid or
other federal or state healthcare programs, residents of Massachusetts, or US
territories (other than Puerto Rico). The free (1) FreeStyle Libre 2 system
sensor or (1) FreeStyle Libre 3 system sensor is provided as a sample and is
limited to one sample per eligible person per product identification number.
The FreeStyle Libre 2 system sensor or FreeStyle Libre 3 system sensor cannot
be re-sold, traded nor submitted to any third-party payer for reimbursement and
is not provided as any inducement for future purchases. The free sample card is
not health insurance.

‡ Based on the
sensor being replaced once every 14 days, and scanned at least once every 8
hours. The FreeStyle Libre 3 system does not require scanning.

§ Fingersticks are
required if your glucose alarms and readings do not match symptoms or when you
see Check Blood Glucose symbol during the first twelve hours.

‖ Based on prescription claims for
the aggregate of patients covered by Commercial insurance, Managed Medicare,
Managed Medicaid using the FreeStyle Libre personal CGM systems versus
competitors’
CGM systems. Does not include fee-for-service Medicare, fee-for-service
Medicaid, and uninsured patients. The actual amount a patient pays may vary.
The FreeStyle Libre personal CGM systems require a prescription.

¶ In comparison
with Dexcom G7 and Medtronic Guardian Connect System User Guide.

# Alarm
notifications will only be received when alarms settings are enabled and turned
on and sensor is within 33 feet unobstructed of the reading device.

** The FreeStyle
Libre 3 app is only compatible with certain mobile devices and operating
systems. Please check our compatibility guide for more information about device
compatibility before using the app.

†† Based on a
comparison of list prices of the FreeStyle Libre 3 system versus competitors’
CGM systems, assuming annual use of one receiver (or equivalent hardware) and
quantity of transmitters and/or sensors according to use life. The actual cost
to patients may or may not be lower than other CGM systems, depending on the
amount covered by insurance, if any.

References: 1. Data
on file. Abbott Diabetes Care, Inc. 2. FreeStyle Libre 3 User's Manual. 3.
Alva, Shridhara, et al. "Accuracy of the Third Generation of a 14-Day
Continuous Glucose Monitoring System." Diabetes Therapy 14, no. 4 (2023):
767-776. https://doi.org/10.1007/s13300-023-01385-6. 4. Based on FSL3 User's
Manual, Dexcom G7 CGM User Guide, and Medtronic Guardian Connect System User
Guide.